0001775819-23-000002.txt : 20230825 0001775819-23-000002.hdr.sgml : 20230825 20230825145736 ACCESSION NUMBER: 0001775819-23-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230825 DATE AS OF CHANGE: 20230825 EFFECTIVENESS DATE: 20230825 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Genesis Therapeutics, Inc. CENTRAL INDEX KEY: 0001775819 IRS NUMBER: 833198117 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-490705 FILM NUMBER: 231207397 BUSINESS ADDRESS: STREET 1: 1440 CHAPIN AVE STREET 2: SUITE 385 CITY: BURLINGAME STATE: CA ZIP: 94010 BUSINESS PHONE: 203-615-4567 MAIL ADDRESS: STREET 1: 1440 CHAPIN AVE STREET 2: SUITE 385 CITY: BURLINGAME STATE: CA ZIP: 94010 D 1 primary_doc.xml X0708 D LIVE 0001775819 Genesis Therapeutics, Inc. 1440 CHAPIN AVE SUITE 385 BURLINGAME CA CALIFORNIA 94010 203-615-4567 DELAWARE None None Corporation true 2019 EVAN FEINBERG 1440 CHAPIN AVE SUITE 385 BURLINGAME CA CALIFORNIA 94010 Executive Officer Director BENJAMIN SKLAROFF 1440 CHAPIN AVE SUITE 385 BURLINGAME CA CALIFORNIA 94010 Executive Officer WILLIAM MCCARTHY 1440 CHAPIN AVE SUITE 385 BURLINGAME CA CALIFORNIA 94010 Executive Officer LEONARD BELL 1440 CHAPIN AVE SUITE 385 BURLINGAME CA CALIFORNIA 94010 Director PEPTIBOON PRASIT 1440 CHAPIN AVE SUITE 385 BURLINGAME CA CALIFORNIA 94010 Executive Officer Director KRIS JENNER 1440 CHAPIN AVE SUITE 385 BURLINGAME CA CALIFORNIA 94010 Director VIJAY PANDE 1440 CHAPIN AVE SUITE 385 BURLINGAME CA CALIFORNIA 94010 Director Biotechnology Decline to Disclose 06b false 2023-08-10 false true false 0 224025681 224025681 0 false 50 0 0 0 false Genesis Therapeutics, Inc. EVAN FEINBERG EVAN FEINBERG PRESIDENT AND CEO 2023-08-25